Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
CARLA C. NIKKEL
Observed names:
C. Nikkel,
Carla C. Nikkel,
Carla Nikkel,
Nikkel, Carla
ORCID:
0000-0002-7206-1094
Observed ORCID:
0000-0002-7206-1094
OpenAlex ID:
A5091786431
Clinical and Cost-Effectiveness of Insulin Delivery with V-GO® Disposable Insulin Delivery Device Versus Multiple Daily Injections in Patients with Type 2 Diabetes Inadequately Controlled on Basal Insulin
2016
·
Rosemarie Lajara
, Jaime A. Davidson
, et al.
·
Endocrine Practice
·
25
Use of V-Go® Insulin Delivery Device in Patients with Sub-optimally Controlled Diabetes Mellitus: A Retrospective Analysis from a Large Specialized Diabetes System
2015
·
Rosemarie Lajara
, Dianne A. Fetchick
, et al.
·
Diabetes Therapy
·
24
PDF
Clinical Benefits Over Time Associated with Use of V-Go Wearable Insulin Delivery Device in Adult Patients with Diabetes: A Retrospective Analysis
2018
·
David Sutton
, Charissa D. Higdon
, et al.
·
Advances in Therapy
·
21
PDF
Effectiveness of V-Go® for Patients with Type 2 Diabetes in a Real-World Setting: A Prospective Observational Study
2019
·
George Grunberger
, Cheryl R. Rosenfeld
, et al.
·
Drugs - Real World Outcomes
·
19
PDF
The Clinical and Economic Impact of the V-Go® Disposable Insulin Delivery Device for Insulin Delivery in Patients with Poorly Controlled Diabetes at High Risk
2016
·
Rosemarie Lajara
, Carla Nikkel
, et al.
·
Drugs - Real World Outcomes
·
16
PDF
Clinical and economic considerations based on persistency with a novel insulin delivery device versus conventional insulin delivery in patients with type 2 diabetes: A retrospective analysis
2018
·
Beverly Everitt
, H. Courtenay Harrison
, et al.
·
Research in Social and Administrative Pharmacy
·
14
PDF
Clinical Insights Into a New, Disposable Insulin Delivery Device
2015
·
P. Gaye Knutsen
, Cheryl Q. Voelker
, et al.
·
Diabetes Spectrum
·
13
PDF
Efficacy, safety and cost-effectiveness comparison between U-100 human regular insulin and rapid acting insulin when delivered by V-Go wearable insulin delivery device in type 2 diabetes
2020
·
Pablo F Mora
, David R Sutton
, et al.
·
BMJ Open Diabetes Research & Care
·
9
PDF
Multicenter Real-World Assessment of the Effectiveness of V-Go Wearable Insulin Delivery Device in Adult Patients with Type 2 Diabetes (ENABLE Study): A Retrospective Analysis
2020
·
Ripu Hundal
, Stephan Kowalyk
, et al.
·
Medical Devices Evidence and Research
·
4
PDF
Clinical Evaluation of Basal-Bolus Therapy Delivered by the V-Go® Wearable Insulin Delivery Device in Patients with Type 2 Diabetes: A Retrospective Analysis
2020
·
Trisha Zeidan
, Carla Nikkel
, et al.
·
Pharmacy
·
2
PDF
1005-P: Comparison of Hypoglycemia Safety between U-100 Human Regular Insulin and Rapid-Acting Insulin Delivered By V-Go Wearable Insulin Delivery in Type 2 Diabetes
2020
·
PABLO F. MORA
, DAVID R. SUTTON
, et al.
·
Diabetes
987-P: Efficacy and Safety Comparison between U-100 Human Regular Insulin and Rapid-Acting Insulin When Delivered by V-Go Wearable Insulin Delivery in an Older Type 2 Diabetes Population
2020
·
DAVID R. SUTTON
, PABLO F. MORA
, et al.
·
Diabetes
OR30-02 Efficacy and Safety Comparison Between U100 Regular Human Insulin and U100 Rapid Acting Insulin When Delivered by a 24 Hour Wearable Insulin Delivery Device in Type 2 Diabetes
2020
·
Pablo Mora
, David R Sutton
, et al.
·
Journal of the Endocrine Society
PDF
1045-P: Efficacy and Safety of a 24-Hour Wearable Insulin Delivery Device for Basal-Bolus Therapy in Older Adults
2019
·
TRISHA ZEIDAN
, CARLA C. NIKKEL
, et al.
·
Diabetes
1044-P: Insulin Intensification with a 24-Hour Wearable Insulin Delivery Device in Patients Inadequately Controlled with Basal Insulin Therapy
2019
·
TRISHA ZEIDAN
, CARLA C. NIKKEL
, et al.
·
Diabetes
Pdb97 Impact to Diabetes Quality Performance Measures in an Older Adult Population When Using a 24-hour Wearable Insulin Delivery Device for Basal-bolus Insulin Therapy
2019
·
T. Zeidan
, C. Nikkel
, et al.
·
Value in Health
Abstract #269 Clinical Evalution of Basal-Bolus Therapy Delivered By a 24-Hour Wearable Insulin Delivery Device in Patients with Type 2 Diabetes
2019
·
Trisha Zeidan
, Carla Nikkel
, et al.
·
Endocrine Practice
Clinical Outcomes with V-Go in Type 2 Diabetes Based on Duration of Diabetes
2018
·
JANE CASES
, STEPHAN KOWALYK
, et al.
·
Diabetes
Effectiveness of V-Go Wearable Insulin Delivery for Basal-Bolus Therapy—A Multicenter, Retrospective Real-World Evaluation in Type 2 Diabetes
2018
·
RIPU S. HUNDAL
, STEPHAN KOWALYK
, et al.
·
Diabetes
Achievement of Glycemic Targets when Switching from Basal-Bolus Therapy to V-Go for Insulin Delivery in Type 2 Diabetes
2018
·
RIPU S. HUNDAL
, STEPHAN KOWALYK
, et al.
·
Diabetes
Abstract #220 24-Hour Wearable Basal-Bolus Insulin Delivery Device Improves Time in Range and Treatment Satisfaction Over Multiple Daily Injections- A Pilot Study
2018
·
Shreya Parikh
, Jennifer Dyson
, et al.
·
Endocrine Practice
Clinical Benefits over Time Associated with Use of V-Go Wearable Insulin Delivery Device in Adult Patients with Diabetes: A Retrospective Analysis
2018
·
Sutton, David
, Higdon, Charissa D.
, et al.
·
Figshare
Abstract #242: The Impact of Utilizing a Novel Insulin Delivery Device in Patients with Type 2 Diabetes
2017
·
Howard Harrison
, Beverly Everitt
, et al.
·
Endocrine Practice
Abstract #248: Achievement of Glycemic Targets in Patients with Uncontrolled Type 2 Diabetes When Switching to a Wearable Insulin Delivery Device for Insulin Delivery
2017
·
Howard Harrison
, Beverly Everitt
, et al.
·
Endocrine Practice
Abstract #240: Comparison of Two Methods for Intensified Insulin Delivery in Patients with Type 2 Diabetes Inadequately Controlled on Basal Insulin
2016
·
Rosemarie Lajara
, Jaime Davidson
, et al.
·
Endocrine Practice
Show more works
View as search
Works count:
26
Citation count:
147
H-index:
8
I10-index:
7
Year
Topic
Type
